{"id":"placebo-matching-gepotidacin","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Vomiting"}]},"_chembl":{"chemblId":"CHEMBL3317856","moleculeType":"Small molecule","molecularWeight":"448.53"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Gepotidacin belongs to a new class of antibiotics called triazaacenaphthylenes that inhibit bacterial topoisomerases, enzymes essential for DNA unwinding and replication. By blocking these enzymes, gepotidacin prevents bacteria from replicating their DNA and transcribing genes, leading to bacterial cell death. This mechanism differs from fluoroquinolones and provides activity against resistant gram-negative and gram-positive pathogens.","oneSentence":"Gepotidacin is a novel bacterial topoisomerase inhibitor that prevents bacterial DNA replication and transcription by targeting DNA gyrase and topoisomerase IV.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:27:51.455Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Uncomplicated urogenital gonorrhea"},{"name":"Acute bacterial skin and skin structure infections"}]},"trialDetails":[{"nctId":"NCT04187144","phase":"PHASE3","title":"Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2020-04-23","conditions":"Urinary Tract Infections","enrollment":1606},{"nctId":"NCT04020341","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-10-17","conditions":"Urinary Tract Infections","enrollment":1531},{"nctId":"NCT04493931","phase":"PHASE1","title":"Drug-drug Interaction Study of Gepotidacin","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2020-08-14","conditions":"Infections, Bacterial","enrollment":64},{"nctId":"NCT04079790","phase":"PHASE1","title":"Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-09-04","conditions":"Infections, Bacterial","enrollment":34},{"nctId":"NCT02202187","phase":"PHASE1","title":"A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-09-26","conditions":"Infections, Respiratory Tract","enrollment":48},{"nctId":"NCT01706315","phase":"PHASE1","title":"This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-10-17","conditions":"Infections, Respiratory Tract","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo matching gepotidacin","genericName":"Placebo matching gepotidacin","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Gepotidacin is a novel bacterial topoisomerase inhibitor that prevents bacterial DNA replication and transcription by targeting DNA gyrase and topoisomerase IV. Used for Uncomplicated urogenital gonorrhea, Acute bacterial skin and skin structure infections.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}